Why the study?
What is the prevalence of metabolic syndrome in patients with chronic heart failure compared to the general population in Japan?
What is the prevalence of metabolic syndrome in patients with chronic heart failure compared to the general population in Japan?
Metabolic syndrome is highly prevalent in Japanese patients with chronic heart failure, suggesting its components may contribute to the development of both ischemic and non-ischemic CHF.
May warrant MetS screening in Japanese CHF patients; leaves open causal contribution to ischemic and non-ischemic disease.
The prevalence of MetS in CHF patients is more than double compared with the general population in Japan and suggest that the metabolic components may have a substantial effect on the development of both ischemic and non-ischemic CHF.
No takes yet. Share an insight, caveat, or question.
Miura et al. (2010) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: